| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 25,000 | $8.03 | $200,735.00 | +0.7% | +42.1% | +429.1% | |
| Nov 14, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Deflin Gayle55 | Director | Sell | 4,163 | $55.45 | $230,838.35 | -60.5% | -0.5% | -19.2% | |
| Nov 14, 2023 | PRGO Perrigo Co Plc | Lockwood-Taylor Patrick48 | CEO | Buy | 11,000 | $28.99 | $318,868.00 | New | +12.1% | -7.2% | |
| Nov 14, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 59,250 | $55.67 | $3,298,474.68 | -14.0% | -0.5% | -19.2% | |
| Nov 14, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Mottola Frank | SVP, Quality, Gmp, Ops, It | Sell | 1,110 | $28.13 | $31,224.30 | -16.3% | +1.1% | +34.7% | |
| Nov 14, 2023 | PRGO Perrigo Co Plc | Bezerra Eduardo Guarita45 | EVP &Chief Financial Officer | Buy | 5,000 | $29.18 | $145,881.50 | +145.9% | +12.1% | -7.2% | |
| Nov 14, 2023 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 90,500 | $0.88 | $79,461.35 | -1.2% | - | - | |
| Nov 13, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 102,416 | $0.07 | $7,572.62 | - | - | - | |
| Nov 13, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 5,000 | $52.50 | $262,500.00 | -12.2% | +4.6% | -10.9% | |
| Nov 13, 2023 | ANIP Ani Pharmaceuticals Inc | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $52.03 | $13,007.50 | -0.7% | +10.4% | +18.1% | |
| Nov 13, 2023 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 341 | $63.57 | $21,677.37 | -0.6% | -12.4% | +31.9% | |
| Nov 13, 2023 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | CEO | Sell | 11,780 | $63.72 | $750,611.00 | -1.8% | -12.4% | +31.9% | |
| Nov 10, 2023 | ANIP Ani Pharmaceuticals Inc | Mutz Christopher | Head Of Rare Disease | Sell | 3,000 | $52.47 | $157,410.00 | -4.5% | +7.2% | +17.8% | |
| Nov 9, 2023 | MRK Merck & Co., Inc. | Oosthuizen Johannes Jacobus | President, U.s. Market | Sell | 2,081 | $102.38 | $213,061.31 | -10.3% | +25.4% | +3.2% | |
| Nov 8, 2023 | MRK Merck & Co., Inc. | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sell | 43,823 | $105.03 | $4,602,668.34 | -28.2% | +22.4% | -0.5% | |
| Nov 8, 2023 | DERM Journey Medical Corp | Paley Jeffrey59 | Director | Sell | 2,500 | $3.51 | $8,771.40 | -1.1% | +16.2% | +51.9% | |
| Nov 8, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 27,399 | $6.83 | $187,221.93 | -2.2% | +34.2% | +236.5% | |
| Nov 6, 2023 | LLY Eli Lilly & Co | Zakrowski Donald A | SVP, Finance, &CAO | Sell | 670 | $571.10 | $382,637.00 | -12.5% | +18.7% | +35.4% | |
| Nov 6, 2023 | BHC Bausch Health Companies Inc. | Carson Seana60 | EVP, General Counsel | Sell | 43 | $7.61 | $327.23 | - | +4.3% | +30.1% | |
| Nov 3, 2023 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 20,000 | $15.00 | $300,000.00 | -86.3% | -10.1% | -17.2% | |
| Nov 2, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $225.76 | $1,354,553.96 | -3.0% | -5.9% | +63.9% | |
| Nov 2, 2023 | EGRX Eagle Pharmaceuticals, Inc. | Tarriff Scott | CEO | Sell | 21,619 | $13.84 | $299,309.28 | -1.9% | - | - | |
| Nov 1, 2023 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 20,000 | $14.12 | $282,400.00 | -86.3% | -7.5% | -16.0% | |
| Nov 1, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $45.30 | $22,651.05 | -0.6% | +20.9% | +11.2% | |
| Oct 27, 2023 | MRMD Marimed Inc. | Shaw Timothy | Chief Operating Officer | Sell | 33,272 | $0.32 | $10,680.31 | -0.4% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.